Forecast & RatingOnly 1 analyst currently covers ALTAMIRA THERAPEUTICS LTD (CYTOF.US), with a price target of $5.31. The sample is very small, so treat this as a reference only. Data as of Jan 6, 2026; this does not constitute investment advice.
Dec 27, 2024Price forecast
$5.318188.49%
Forecast & Rating-
0analysts
Target price forecast
Forecast dateJul 27, 2025
Forecast met0.0%
Stock price$0.07
Avg. target$5.3
High target$5
Low target$5
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.